β-Nicotinamide Mononucleotide protects against endotoxemia-induced myocardial injury through Sirt5-dependent desuccinylation of succinate dehydrogenase Hongmei Tao, Qian Dong, Yang Long, Ling Liu, Shu Qin, Yu Wang European Journal of Pharmacology.2026; 1015: 178562. CrossRef
Immunonutrition: Another Player on the MASLD Field Iván López-Méndez, Misael Uribe, Eva Juárez-Hernández International Journal of Molecular Sciences.2025; 26(18): 8928. CrossRef
The current standard of care for severe alcoholic hepatitis (SAH) has several limitations in that only up to one-third of patients are eligible for steroid therapy. Additionally, steroids have their own issues: a portion of patients do not respond, while there is doubtful long-term benefit in those who do and a large proportion are ineligible to receive steroids entirely and hence have no definitive options for treatment. As such, there is a large gap between the problem and the available solutions. Alcohol causes dysbiosis and also disrupts gut barrier function, consequently promoting the translocation of microbial lipopolysaccharide into the portal circulation and liver. Therefore, probiotics, prebiotics, antibiotics, or transplantation of gut microbiota are likely to attenuate the dysbiosis-related liver insult. Fecal microbiota transplantation (FMT) is expected to have a role in managing alcoholic liver disease in general and SAH in particular by correcting dysbiosis, the primary insult. Results from mouse studies have suggested beyond doubt that alcohol-related liver injury is transferrable and also treatable by adopting FMT from suitable donors. Initial human trials from our center have affirmed benefits in human subjects with SAH as well, with both improvements in disease severity and as well as the rate of survival. Further studies addressing the head-to-head comparison of steroids and FMT are ongoing. Available preliminary data are promising and FMT and/or gut microbial modulation might become the standard of care in the near future for managing alcohol-related liver diseases, especially alcoholic hepatitis, with greater applicability, improved acceptability, and minimal side effects.
Citations
Citations to this article as recorded by
Alcohol-Related Liver Disease Haripriya Maddur, Steven Flamm Clinics in Liver Disease.2026; 30(1): 45. CrossRef
Puerarin ameliorates alcoholic liver disease by regulating intestinal flora and MAPK/Nrf2 signalling pathways Zicheng Wang, Yingying Yu, Wanjun Shao, Yuhao Zhao, Zhe Li, Jiaming Han, Jingyu Wen, Yongchun Meng, Ying Lin, Shaoping Wang Ecotoxicology and Environmental Safety.2026; 309: 119699. CrossRef
Gut Microbiome and Bile Acid Metabolism in Liver Disease: Mechanisms, Clinical Implications, and Therapeutic Opportunities Huiping Zhou, Yi Huang, Chen Chen, Meiyi Song, Phillip.B. Hylemon Pharmacological Reviews.2026; : 100120. CrossRef
Prospective study on time-to-tertiary care in alcohol-associated hepatitis: space–time coordinates as prognostic tool and therapeutic target Ľubomír Skladaný, Daniela Žilinčanová, Natália Kubánek, Svetlana Adamcová Selčanová, Daniel Havaj, Lukáš Laffers, Michal Žilinčan, Alvi H Islam, Juan Pablo Arab, Tomáš Koller Alcohol and Alcoholism.2025;[Epub] CrossRef
The crosstalk between gut microbiota and microbiota-derived metabolites in hepatocellular carcinoma Sang Jun Yoon, Seul Ki Han, Tae Suk Kim, Ki Tae Suk, Dae Hee Choi, Young Don Kim, Moon Young Kim, Gab Jin Cheon, Soon Koo Baik, Dong Joon Kim Critical Reviews in Microbiology.2025; 51(6): 1315. CrossRef
Prolonged Intestinal Ethanol Absorption and Oxidative Stress: Revisiting the Gut–Liver Axis in Alcohol-Associated Disease Beom Sun Chung, Keungmo Yang, Chihyun Park, Tom Ryu International Journal of Molecular Sciences.2025; 26(12): 5442. CrossRef
Correction of vaginal microbiocenosis in bacterial vaginosis. Promising areas G.O. Grechkanev, I.O. Strelets, N.N. Nikishov, E.V. Sinitsina, A.N. Nikishova Russian Bulletin of Obstetrician-Gynecologist.2025; 25(4): 44. CrossRef
Alcohol-Induced Oxidative Stress and Gut–Liver–Brain Crosstalk: Expanding the Paradigm from ALD to MetALD Jeong-Yoon Lee, Young-Min Jee, Keungmo Yang, Tom Ryu Antioxidants.2025; 14(10): 1196. CrossRef
A systematic review and meta-analysis on the efficacy of fecal microbiome transplantation in patients with severe alcohol-associated hepatitis Evance Pakuwal, Jin Lin Tan, Richard J. Woodman, Amanda J. Page, Andrea M. Stringer, Mohamed Asif Chinnaratha European Journal of Gastroenterology & Hepatology.2025; 37(11): 1260. CrossRef
Fecal Microbiota Transplant in Alcoholic Liver Disease: A Review of Current Literature Alexander Grieme, Yizhong Wu, Kalee Moore, Manuel Garza, Eric R. Smith, Erica Yatsynovich, Thomas J. Egeland, Rajesh Shah Therapeutics.2025; 3(1): 2. CrossRef
Intestinal microbiome-targeted therapies improve liver function in alcohol-related liver disease by restoring bifidobacteria: a systematic review and meta-analysis Xin Chi, Xiu Sun, Danying Cheng, Shunai Liu, Calvin Q. Pan, Huichun Xing Frontiers in Pharmacology.2024;[Epub] CrossRef
Chronic Liver Disease and Promising Therapeutic Strategy: A Concise Review Han Yu, Zhijun Wang, Gang Zhao Pharmacognosy Magazine.2024; 20(4): 1031. CrossRef
Inflammatory liver diseases and susceptibility to sepsis Hong Lu Clinical Science.2024; 138(7): 435. CrossRef
Fecal microbiota transplantation from female donors restores gut permeability and reduces liver injury and inflammation in middle-aged male mice exposed to alcohol Arantza Lamas-Paz, Mariana Mesquita, Marcos Garcia-Lacarte, Olga Estévez-Vázquez, Raquel Benedé-Ubieto, Alejandro H. Gutierrez, Hanghang Wu, Hector Leal Lasalle, Javier Vaquero, Rafael Bañares, Eduardo Martínez-Naves, Sergio Roa, Yulia A. Nevzorova, Gonza Frontiers in Nutrition.2024;[Epub] CrossRef
Digestive dynamics: Unveiling interplay between the gut microbiota and the liver in macronutrient metabolism and hepatic metabolic health Mrunmayee R. Kandalgaonkar, Virender Kumar, Matam Vijay‐Kumar Physiological Reports.2024;[Epub] CrossRef
Inflammatory Response in the Pathogenesis and Treatment of Hepatocellular Carcinoma: A Double-Edged Weapon Linda Galasso, Lucia Cerrito, Valeria Maccauro, Fabrizio Termite, Irene Mignini, Giorgio Esposto, Raffaele Borriello, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco International Journal of Molecular Sciences.2024; 25(13): 7191. CrossRef
Faecal microbiota transplantation associated adverse events Rafal Patryn, Natalia Kazmierczak-Wojtas, Lucyna Bulas, Olga Boretska, Monika Szkultecka-Debek, Mariola Drozd, Tomasz Blicharski Current Issues in Pharmacy and Medical Sciences.2024; 37(3): 171. CrossRef
Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives Mengyao Yan, Shuli Man, Long Ma, Lanping Guo, Luqi Huang, Wenyuan Gao Clinical and Molecular Hepatology.2024; 30(4): 620. CrossRef
3PM-guided innovation in treatments of severe alcohol-associated hepatitis utilizing fecal microbiota transplantation Lubomir Skladany, Natalia Kubanek, Svetlana Adamcova Selcanova, Daniela Zilincanova, Daniel Havaj, Karolina Sulejova, Katarina Soltys, Lucia Messingerova, Michal Lichvar, Lukas Laffers, Michal Zilincan, Eva Honsova, Peter Liptak, Peter Banovcin, Jan Bures EPMA Journal.2024; 15(4): 677. CrossRef
Mapping the relationship between alcohol use disorder and gut microbiota: a 20-year bibliometric study Ao Xiang, Yonglong Chang, Li Shi, Xuhui Zhou Frontiers in Microbiology.2024;[Epub] CrossRef
Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease Hui Gao, Yanchao Jiang, Ge Zeng, Nazmul Huda, Themis Thoudam, Zhihong Yang, Suthat Liangpunsakul, Jing Ma eGastroenterology.2024; 2(4): e100104. CrossRef
Conventional type 1 dendritic cells protect against gut barrier disruption via maintaining Akkermansia muciniphila in alcoholic steatohepatitis Liuyi Hao, Wei Zhong, Jongmin Woo, Xiaoyuan Wei, Hao Ma, Haibo Dong, Wei Guo, Xinguo Sun, Ruichao Yue, Jiangchao Zhao, Qibin Zhang, Zhanxiang Zhou Hepatology.2023; 78(3): 896. CrossRef
TRPV6 deficiency attenuates stress and corticosterone-mediated exacerbation of alcohol-induced gut barrier dysfunction and systemic inflammation Avtar S. Meena, Pradeep K. Shukla, Rupa Rao, Cherie Canelas, Joseph F. Pierre, RadhaKrishna Rao Frontiers in Immunology.2023;[Epub] CrossRef
The Role of Microbiota in Liver Transplantation and Liver Transplantation-Related Biliary Complications Ulrich Wirth, Tianxiao Jiang, Josefine Schardey, Katharina Kratz, Mingming Li, Malte Schirren, Florian Kühn, Alexandr Bazhin, Jens Werner, Markus Guba, Christian Schulz, Joachim Andrassy International Journal of Molecular Sciences.2023; 24(5): 4841. CrossRef
Gut Microbiota: A Future Clinical Magic Bullet to Manifest Pathogenic Disease in the Current Future Pooja Rani Mina Journal of Pure and Applied Microbiology.2023; 17(1): 51. CrossRef
The human microbiome and gut–liver axis in people living with HIV Maria J. Duarte, Phyllis C. Tien, Ma Somsouk, Jennifer C. Price Current HIV/AIDS Reports.2023; 20(3): 170. CrossRef
Exploring the diversity of blood microbiome during liver diseases: Unveiling Novel diagnostic and therapeutic Avenues Dinakaran Vasudevan, Arulraj Ramakrishnan, Ganesan Velmurugan Heliyon.2023; 9(11): e21662. CrossRef
Fecal Microbiota Transplantation in Liver Cirrhosis Adrian Boicean, Victoria Birlutiu, Cristian Ichim, Olga Brusnic, Danusia Maria Onișor Biomedicines.2023; 11(11): 2930. CrossRef
Advances in the management of alcohol-associated liver disease Ahmad Anouti, Thomas A Kerr, Mack C Mitchell, Thomas G Cotter Gastroenterology Report.2023;[Epub] CrossRef
Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation Sergii Tkach, Andrii Dorofeyev, Iurii Kuzenko, Nadiya Boyko, Tetyana Falalyeyeva, Luigi Boccuto, Emidio Scarpellini, Nazarii Kobyliak, Ludovico Abenavoli Medicina.2022; 58(1): 84. CrossRef
Intestinal Microbiota Contributes to the Improvement of Alcoholic Hepatitis in Mice Treated With Schisandra chinensis Extract Jun-Yan Xiang, Yan-Yu Chi, Jin-Xin Han, Xinyu Shi, Yong Cai, Hongyu Xiang, Qiuhong Xie Frontiers in Nutrition.2022;[Epub] CrossRef
Recent insights into the hepatoprotective effects of lactic acid bacteria in alcoholic liver disease Xiaoqian Sun, Jingjing Shi, Lingyu Kong, Qiyuan Shen, Xiaoqun Zeng, Zhen Wu, Yuxing Guo, Daodong Pan Trends in Food Science & Technology.2022; 125: 91. CrossRef
Predictive and Prognostic Roles of Gut Microbial Variation in Liver Transplant Hon Jen Wong, Wen Hui Lim, Cheng Han Ng, Darren Jun Hao Tan, Glenn K. Bonney, Alfred W. C. Kow, Daniel Q. Huang, Mohammad Shadab Siddiqui, Mazen Noureddin, Nicholas Syn, Mark D. Muthiah Frontiers in Medicine.2022;[Epub] CrossRef
Principles of diagnosis and treatment of alcohol-induced liver fibrosis D. V. Garbuzenko Meditsinskiy sovet = Medical Council.2022; (7): 104. CrossRef
TRPV6 channel mediates alcohol-induced gut barrier dysfunction and systemic response Avtar S. Meena, Pradeep K. Shukla, Briar Bell, Francesco Giorgianni, Rebeca Caires, Carlos Fernández-Peña, Sarka Beranova, Eitaro Aihara, Marshall H. Montrose, Mehdi Chaib, Liza Makowski, Indira Neeli, Marko Z. Radic, Valeria Vásquez, Jonathan H. Jaggar, Cell Reports.2022; 39(11): 110937. CrossRef
Utilizing Gut Microbiota to Improve Hepatobiliary Tumor Treatments: Recent Advances Hao Qin, Baowen Yuan, Wei Huang, Yan Wang Frontiers in Oncology.2022;[Epub] CrossRef
Alcohol-Related Liver Disease: An Overview on Pathophysiology, Diagnosis and Therapeutic Perspectives Yoonji Ha, Inju Jeong, Tae Hyun Kim Biomedicines.2022; 10(10): 2530. CrossRef
Pathophysiological Prerequisites and Therapeutic Potential of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis D. V. Garbuzenko The Russian Archives of Internal Medicine.2022; 12(5): 352. CrossRef
Finding a Balance in the Vaginal Microbiome: How Do We Treat and Prevent the Occurrence of Bacterial Vaginosis? Rebecca Jane Joseph, Hooi-Leng Ser, Yi-He Kuai, Loh Teng-Hern Tan, Valliammai Jayanthi Thirunavuk Arasoo, Vengadesh Letchumanan, Lijing Wang, Priyia Pusparajah, Bey-Hing Goh, Nurul-Syakima Ab Mutalib, Kok-Gan Chan, Learn-Han Lee Antibiotics.2021; 10(6): 719. CrossRef
From intestinal dysbiosis to alcohol-associated liver disease Beatriz Garcia Mendes, Bernd Schnabl Clinical and Molecular Hepatology.2020; 26(4): 595. CrossRef
Alcohol and hepatocarcinogenesis Makiko Taniai Clinical and Molecular Hepatology.2020; 26(4): 736. CrossRef
First
Prev
